Pin It

An Israeli biotech company is developing a vaccine for cancer that it says can help prevent the return of the lethal disease for 90% of the different types of cancer.

Vaxil BioTherapeutics based in Nes Ziona has been developing ImMucin for more than five years, and already has seen strong success in testing indicating it can be a vital tool in combating cancer. The disease kills eight million people worldwide per year, and sees 14 million new cases diagnosed annually according to the World Health Organization.

"Vaxil is developing a drug to keep the cancer from coming back," Vaxil's CFO Julian Levy told NoCamels. "We are trying to harness the natural power of the immune system to fight against cancer by seeking out cancer cells and destroying them."

To read more, click here.